Cosmos Health [COSM] vs Cencora [COR] Detailed Stock Comparison

Cosmos Health Inc.

NASDAQ
Loading...

Cencora Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Cosmos Health Inc. wins in 4 metrics, Cencora Inc. wins in 14 metrics, with 0 ties. Cencora Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Cosmos Health Inc. Cencora Inc. Better
P/E Ratio (TTM) N/A 37.46 N/A
Price-to-Book Ratio 0.78 31.84 Cosmos Health Inc.
Debt-to-Equity Ratio 108.39 472.58 Cosmos Health Inc.
PEG Ratio 4.98 2.62 Cencora Inc.
EV/EBITDA -2.43 13.93 Cencora Inc.
Profit Margin (TTM) -29.33% 0.50% Cencora Inc.
Operating Margin (TTM) -57.07% 1.18% Cencora Inc.
EBITDA Margin (TTM) N/A 1.18% N/A
Return on Equity -89.13% 133.47% Cencora Inc.
Return on Assets (TTM) -17.26% 3.33% Cencora Inc.
Free Cash Flow (TTM) $-8.60M $3.21B Cencora Inc.
Dividend Yield N/A 0.64% N/A
1-Year Return -43.18% -7.51% Cencora Inc.
Price-to-Sales Ratio (TTM) 0.27 0.19 Cencora Inc.
Enterprise Value $36.90M $69.11B Cencora Inc.
EV/Revenue Ratio 0.57 0.21 Cencora Inc.
Gross Profit Margin (TTM) 10.55% 3.58% Cosmos Health Inc.
Revenue per Share (TTM) $2 $1,680 Cencora Inc.
Earnings per Share (Diluted) $-0.63 $8.34 Cencora Inc.
Beta (Stock Volatility) 4.46 0.72 Cencora Inc.
Short % of Float 0.51% 3.01% Cosmos Health Inc.

Cosmos Health Inc. vs Cencora Inc. Stock Performance Analysis

Loading Price Chart...

COSM
COR

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Cosmos Health Inc.-5.38%0.00%-27.78%-35.00%-52.73%-49.02%
Cencora Inc.-0.42%-2.19%-12.78%-28.93%-24.48%-21.85%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Cosmos Health Inc.-43.18%-92.77%-99.79%-99.83%-99.88%-99.92%
Cencora Inc.-7.51%54.34%130.38%251.92%567.56%1,169.37%

Performance & Financial Health Analysis: Cosmos Health Inc. vs Cencora Inc.

MetricCOSMCOR
Market Information
Market Cap i$18.14M$60.57B
Market Cap CategoryMicro capLarge cap
10 Day Avg. Volume i2,607,3681,221,804
90 Day Avg. Volume i1,107,7491,464,685
Last Close$0.25$263.71
52 Week Range$0.25 - $1.32$244.82 - $377.54
% from 52W High-81.29%-30.15%
All-Time High$500.00 (May 16, 2011)$377.53 (Nov 25, 2025)
% from All-Time High-99.95%-30.15%
Growth Metrics
Quarterly Revenue Growth0.39%0.06%
Quarterly Earnings Growth0.39%0.15%
Financial Health
Profit Margin (TTM) i-0.29%0.01%
Operating Margin (TTM) i-0.57%0.01%
Return on Equity (TTM) i-0.89%1.33%
Debt to Equity (MRQ) i108.39472.58
Cash & Liquidity
Book Value per Share (MRQ)$0.45$9.81
Cash per Share (MRQ)$0.02$9.01
Operating Cash Flow (TTM) i$-8,447,614$4.29B
Levered Free Cash Flow (TTM) i$-11,698,862$3.46B
Dividends
Last 12-Month Dividend Yield iN/A0.64%
Last 12-Month Dividend iN/A$2.30

Valuation & Enterprise Metrics Analysis: Cosmos Health Inc. vs Cencora Inc.

MetricCOSM (Apr 24, 2026)COR (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) iN/A37.46
Forward P/E i4.9815.94
PEG Ratio i4.982.62
Price to Sales (TTM) i0.270.19
Price to Book (MRQ) i0.7831.84
Market Capitalization
Market Capitalization i$18.14M$60.57B
Enterprise Value i$36.90M$69.11B
Enterprise Value Metrics
Enterprise to Revenue i0.570.21
Enterprise to EBITDA i-2.4313.93
Risk & Other Metrics
Beta i4.460.72
Book Value per Share (MRQ) i$0.45$9.81

Financial Statements Comparison: Cosmos Health Inc. vs Cencora Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCOSM (2025)COR (2025)
Revenue/Sales i65.27M321.33B
Cost of Goods Sold i57.38M309.85B
COGS % of Revenue i87.9%96.4%
Gross Profit i7.90M11.48B
Gross Margin i12.1%3.6%
Research & Development i519,363N/A
Operating Income (EBIT) i-16.54M3.93B
Operating Margin i-25.3%1.2%
EBITDA i-16.95M5.05B
EBITDA Margin i-26.0%1.6%
Pre-Tax Income i-19.14M2.26B
Pre-Tax Income % of Revenue i-29.3%0.7%
Income Tax i0690.52M
Income Tax % of Revenue i0.0%0.2%
Net Income (Profit) i-19.14M1.57B
Profit Margin i-29.3%0.5%

Balance Sheet & Liquidity Metrics

MetricCOSM (2025)COR (2025)
Cash & Equivalents i715,6744.36B
Total Current Assets i38.39M52.24B
Total Current Assets % of Revenue i58.8%16.3%
Total Current Liabilities i38.27M57.82B
Total Current Liabilities % of Revenue i58.6%18.0%
Long-Term Debt i6.23M7.54B
Long-Term Debt % of Revenue i9.5%2.3%
Total Shareholders Equity i18.42M1.75B
Retained Earnings i-133.17M6.53B
Retained Earnings % of Revenue i-204.0%2.0%
Property, Plant & Equipment i600,6100

Cash Flow Statement Comparison

MetricCOSM (2025)COR (2025)
Operating Cash Flow i-12.53M2.91B
Operating Cash Flow % of Revenue i-19.2%0.9%
Capital Expenditures i-55,675N/A
Free Cash Flow i-8.60M3.21B
FCF Margin i-13.2%1.0%
Debt Repayment i-28.60M-133.45B
Common Stock Repurchase iN/A-435.47M

Short Interest & Institutional Ownership Analysis

MetricCOSMCOR
Shares Short i159,8195.16M
Short Ratio i0.423.41
Short % of Float i0.51%3.01%
Shares Outstanding i41.07M194.52M
Float Shares i37.25M183.99M
% Held by Insiders i26.51%4.23%
% Held by Institutions i5.93%97.08%
% Held by Public i67.56%-1.31%

Dividend Analysis & Yield Comparison: Cosmos Health Inc. vs Cencora Inc.

MetricCOSMCOR
Last 12-Month Dividend iN/A$2.30
Last 12-Month Dividend Yield iN/A0.64%
3-Year Avg Annual Dividend iN/A$2.13
3-Year Avg Dividend Yield iN/A0.22%
3-Year Total Dividends iN/A$6.40
Ex-Dividend DateN/AFeb 13, 2026